Abstract
The muscle disease field has benefited enormously from the increasing availability of genomic resources derived from the human genome mapping and allied projects. Although a number of skeletal and cardiac disorders are still at the linkage or candidate gene analysis stage, genes have been identified for the most common ones. The increasing variety of genes involved makes genetic screens an essential tool for more precise diagnosis and better classification of these disorders. The mouse represents the system of choice for the study of muscular dystrophies and cardiomyopathies but, not surprisingly, many murine models often show phenotypic differences between human and mouse. Only a handful of spontaneous or targeted mouse mutants are available within the field of muscle diseases compared to the increasing genetic complexity of myopathies and cardiomyopathies identified in humans. This shortage has been identified in other inherited diseases and has contributed to the revival of ENU (ethylnitrosourea) mutagenesis. Several large-scale ENU mutagenesis programs set up worldwide should provide allelic collections of mutants for pathologically interesting genes and uncover new gene functions. An effective integration between high throughput production of mutants, DNA-chip based expression analysis and the comprehensive maps derived from the human and mouse genome projects will make possible systematic studies of mammalian gene function, facilitating the identification of better mouse models.
Keywords: Muscle Diseases, Dystrophin glycoprotein complex DGC, Limb girdle Muscular dystrophy LGMD, Muscular dystrophy CMD, Cardiomyopathies, Mutagenesis, Muscle lim protein MLP
Current Genomics
Title: Inherited Muscle Diseases Towards Improvements of the Mouse Model Catalogue
Volume: 1 Issue: 3
Author(s): Gonzalo Blanco
Affiliation:
Keywords: Muscle Diseases, Dystrophin glycoprotein complex DGC, Limb girdle Muscular dystrophy LGMD, Muscular dystrophy CMD, Cardiomyopathies, Mutagenesis, Muscle lim protein MLP
Abstract: The muscle disease field has benefited enormously from the increasing availability of genomic resources derived from the human genome mapping and allied projects. Although a number of skeletal and cardiac disorders are still at the linkage or candidate gene analysis stage, genes have been identified for the most common ones. The increasing variety of genes involved makes genetic screens an essential tool for more precise diagnosis and better classification of these disorders. The mouse represents the system of choice for the study of muscular dystrophies and cardiomyopathies but, not surprisingly, many murine models often show phenotypic differences between human and mouse. Only a handful of spontaneous or targeted mouse mutants are available within the field of muscle diseases compared to the increasing genetic complexity of myopathies and cardiomyopathies identified in humans. This shortage has been identified in other inherited diseases and has contributed to the revival of ENU (ethylnitrosourea) mutagenesis. Several large-scale ENU mutagenesis programs set up worldwide should provide allelic collections of mutants for pathologically interesting genes and uncover new gene functions. An effective integration between high throughput production of mutants, DNA-chip based expression analysis and the comprehensive maps derived from the human and mouse genome projects will make possible systematic studies of mammalian gene function, facilitating the identification of better mouse models.
Export Options
About this article
Cite this article as:
Blanco Gonzalo, Inherited Muscle Diseases Towards Improvements of the Mouse Model Catalogue, Current Genomics 2000; 1 (3) . https://dx.doi.org/10.2174/1389202003351427
DOI https://dx.doi.org/10.2174/1389202003351427 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Alzheimer Disease and Diabetes Mellitus: Do They have Anything in Common?
Current Alzheimer Research Biological Active Ingredients of Traditional Chinese Herb Astragalus membranaceus on Treatment of Diabetes: A Systematic Review
Mini-Reviews in Medicinal Chemistry Current Status of Therapeutic Angiogenesis with Protein, Gene and Cell Therapy
Current Drug Therapy Hypertensive Heart Disease and the Role of Aldosterone Antagonists
Current Hypertension Reviews Cathinone Neurotoxicity (“The “3Ms”)
Current Neuropharmacology Drug Disposition in Pathophysiological Conditions
Current Drug Metabolism Dapagliflozin Protects H9c2 Cells Against Injury Induced by Lipopolysaccharide via Suppression of CX3CL1/CX3CR1 Axis and NF-κB Activity
Current Molecular Pharmacology Membrane Rafts in the Respiratory System
Current Respiratory Medicine Reviews Evolution and Analysis of Heterogeneity in the Clinical Expression of Aortic Diseases Similar to Marfan’s Syndrome: Challenge and Art in Clinical Diagnosis
Current Rheumatology Reviews Insulin Resistance, Small LDL Particles, and Risk for Atherosclerotic Disease
Current Vascular Pharmacology Mitochondrial and Nuclear Genes of Mitochondrial Components in Cancer
Current Genomics Cardiac Telocytes
Current Stem Cell Research & Therapy Tracking Stem Cell Therapy in the Myocardium: Applications of Positron Emission Tomography
Current Pharmaceutical Design Inflammation, Oxidation, Caloric Expenditure and Cognitive Impairment in Brazilian Elderly Assisted at Primary Care
Current Alzheimer Research N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP): Potential target molecule in research of heart, kidney and brain
Current Pharmaceutical Design Adipose Tissue and Bone Marrow as Sources for Cell-based Therapeutic Angiogenesis in Ischemic Tissues: Biological Foundation and Clinical Prospects for Age-related Vascular Disease
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) New Applications of Oleanolic Acid and its Derivatives as Cardioprotective Agents: A Review of their Therapeutic Perspectives
Current Pharmaceutical Design Short-term RR-Interval Power Spectral Analysis as a New Tool to Stratify the Risk of Sudden Death in Various Cardiovascular Conditions
Vascular Disease Prevention (Discontinued) Aldose Reductase, Still a Compelling Target for Diabetic Neuropathy
Current Drug Targets Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Apoptosis
Current Pharmaceutical Design